VieCure

VieCure, founded in 2015 by Dr. Fred Ashbury and Gerry Hogue, operates as a health technology company focused on democratizing precision oncology. The company is headquartered in Greenwood Village, Colorado, and serves community oncology care centers. Dr. Ashbury, the Chief Scientific Officer, brings an extensive background in oncology health services, supportive care, and quality metric development, having held senior roles at institutions like the National Cancer Institute of Canada and published over 80 peer-reviewed articles. This deep expertise in oncology practice underpins the company's core mission.

VieCure addresses the growing complexity of cancer treatment, which is driven by the increasing volume of data from genomics, transcriptomics, and proteomics. The company's business model is centered on providing its proprietary Halo Intelligence Platform to a network of cancer centers, which now includes over 100 locations in the United States, the Bahamas, and Antigua. Revenue is generated through this network, with clients including organizations like the American Oncology Network, Oncology Care Partners, and Commonwealth Cancer Center. The company has secured significant investment to scale its operations, raising a total of $70 million over two funding rounds, including a $25 million Series A in 2021 and a $45 million Series B in 2024, both led by Northpond Ventures.

The Halo Intelligence Platform is an AI-enabled, cloud-based system that functions as a clinical decision support tool and a smart electronic medical record (EMR). It is designed to assist oncologists, hematologists, and other clinicians by integrating disparate patient data—such as medical history, molecular features, pathology reports, and imaging—with the latest clinical evidence and trial protocols. The platform's AI inference engine analyzes this information in real-time to generate personalized treatment plan recommendations at the point of care. Key features include an oncology information management system, a codified clinical knowledge library, integrated telehealth capabilities, voice automation, and mobile applications for both patients and physicians to monitor treatment plans and side effects. By streamlining workflows and providing timely, actionable insights, the system aims to improve treatment efficacy, manage costs, and enhance patient outcomes.

Keywords: oncology informatics, clinical decision support, precision medicine, cancer care platform, AI in oncology, electronic medical records, treatment planning, health technology, oncology EMR, personalized oncology, value-based cancer care, Halo Intelligence, community oncology, multi-omic data integration, Dr. Fred Ashbury, clinical trial matching, patient engagement app, oncology workflow, cancer diagnostics, telehealth oncology, next-generation sequencing integration